跳至主要内容
临床试验/CTRI/2012/11/003120
CTRI/2012/11/003120招募中3 期

Randomised trial of pulsed Actinomycin D versus MTX infusion in low risk gestational trophoblastic neoplasia

Christian Medical College0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with abnormal hCG regression following any type of pregnancy (molar, term, abortion,ectopic) ie
  • (1)hCG plateau for 4 consecutive values over 3 weeks
  • (2)hCG rise of >10% for 3 values over 2 weeks
  • (3)hCG persistence 6 months after molar pregnancy evacuation
  • For staging and pretreatment evaluation, all patients will undergo complete physical and pelvic examination, complete blood cell count, urinalysis, liver and renal function tests, and chest x-ray. Ultrasonography and/or computed tomographic scanning will be performed when clinically indicated. Diagnosis, staging, and risk scoring will be as per International Federation of Gynecology and Obstetrics (FIGO) 2000 criteria for diagnosis and staging for GTN.
  • Low risk gestational trophoblastic disease FIGO score <6

排除标准

  • Choriocarcinoma
  • Any patient with renal, hepatic,haematological disease
  • Prognostic score > 6

研究者

相似试验